APC binds to the novel protein EB1

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Mutations in the Adenomatous Polyposis Coli (APC) gene are fundamental to colorectal cancer development.
• Most APC mutations lead to the truncation of the APC protein's carboxyl terminus.

Purpose of the Study:

• To identify proteins that interact with the carboxyl terminus of APC.
• To understand the functional role of APC in colorectal neoplasia.

Main Methods:

• Utilized the interaction trap two-hybrid system to screen one million human cDNA clones.
• Performed nucleotide sequence analysis to identify interacting proteins.
• Confirmed APC-EB1 association using in vitro binding assays and in vivo studies with monoclonal antibodies against EB1.

Main Results:

• Identified a novel protein, EB1, that associates with the APC carboxyl terminus.
• Confirmed the physical interaction between APC and EB1 both in vitro and in vivo.
• EB1 encodes a 268-amino acid protein with conserved homologues in humans and yeast, suggesting a critical function.

Conclusions:

• EB1 is a novel APC-interacting protein.
• The conserved nature of EB1 suggests an essential role in cellular function.
• Understanding the APC-EB1 interaction may provide insights into the mechanism of APC's tumor-suppressive function in the colon.